Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Octreotide Excluding Dafo Dfl Pls Trs Atc H01Cb02 F D Z 1 7 26 30 6 28 Plus V Option 1X12 Months

Deadline: 05 May 2029

Germany

Ref. No.: 27566975

EMD:Ref Document

Bid Value: Ref Document

904 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Formoterol Excl Dafo Dos Atc R03Ac13 For The Period 07 01 26 06 30 28 Plus V Option 1X12 Months

Deadline: 05 May 2029

Germany

Ref. No.: 27566961

EMD:Ref Document

Bid Value: Ref Document

904 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Granisetron Excl Dafo Pft Atc A04Aa02 For The Period July 1St 2026 June 30Th 28 Plus V Option 1X12 Months

Deadline: 05 May 2029

Germany

Ref. No.: 27566958

EMD:Ref Document

Bid Value: Ref Document

904 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Promethazine Excl Dafo Tei Atc N05Cm22 For The Period 07 01 26 06 30 28 Plus V Option 1X12 Months

Deadline: 05 May 2029

Germany

Ref. No.: 27566949

EMD:Ref Document

Bid Value: Ref Document

904 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Erythropoietin Exclusively Epoetin Alfa And Zeta Atc B03Xa01 For The Period July 1St 2026 June 30Th 2028

Deadline: 05 May 2028

Germany

Ref. No.: 27566932

EMD:Ref Document

Bid Value: Ref Document

539 Days Left

Open House Drug Discount Agreements For The Active Ingredient Cariprazine Atc N05Ax15

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566859

EMD:Ref Document

Bid Value: Ref Document

534 Days Left

Open House Drug Discount Agreements For The Active Ingredient Estradiol Atc G03Ca03

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566852

EMD:Ref Document

Bid Value: Ref Document

534 Days Left

Open House Drug Discount Agreements For The Active Ingredient Follitropin Alfa Atc G03Ga05

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566839

EMD:Ref Document

Bid Value: Ref Document

534 Days Left

Open House Drug Discount Agreements For The Active Ingredient Ganirelix Atc H01Cc01

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566835

EMD:Ref Document

Bid Value: Ref Document

534 Days Left

Open House Drug Discount Agreements For The Active Ingredient Lipegfilgrastim Atc L03Aa14

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566826

EMD:Ref Document

Bid Value: Ref Document

534 Days Left

Open House Drug Discount Agreements For The Active Ingredient Mebeverine Atc A03Aa04

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566822

EMD:Ref Document

Bid Value: Ref Document

534 Days Left

Open House Drug Discount Agreements For The Active Ingredient Tacrolimus Atc L04Ad02

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566816

EMD:Ref Document

Bid Value: Ref Document

534 Days Left

Open House Drug Discount Agreements For The Active Ingredient Pegfilgrastim Atc L03Aa13

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566808

EMD:Ref Document

Bid Value: Ref Document

534 Days Left

Open House Drug Discount Agreements For The Active Ingredient Doravirine Atc J05Ag06

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566804

EMD:Ref Document

Bid Value: Ref Document

534 Days Left

Open House Drug Discount Agreements For The Active Ingredients Bismuth Subcitrate Tetracycline And Metronidazole Atc A02Bd08

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566791

EMD:Ref Document

Bid Value: Ref Document

534 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!